Enhancing Quality of Life for Nursing Home Residents
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00388544 |
Recruitment Status :
Completed
First Posted : October 17, 2006
Last Update Posted : May 9, 2012
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Alzheimer's Disease | Behavioral: Activity matched to interest Behavioral: Activity matched to function Behavioral: Activity matched to both interest and function | Phase 2 |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 128 participants |
Allocation: | Randomized |
Intervention Model: | Single Group Assignment |
Masking: | Double (Care Provider, Outcomes Assessor) |
Primary Purpose: | Diagnostic |
Official Title: | A Prescription for Enhancing Resident Quality of Life |
Study Start Date : | May 2005 |
Actual Primary Completion Date : | February 2010 |
Actual Study Completion Date : | February 2010 |

Arm | Intervention/treatment |
---|---|
Experimental: 1 |
Behavioral: Activity matched to interest
Recreational activities are tailored to subject's style of interest |
Experimental: 2 |
Behavioral: Activity matched to function
Recreational activities are tailored to subjects physical and cognitive functioning |
Experimental: 3 |
Behavioral: Activity matched to both interest and function
Recreational activities are tailored to both style of interest and physical and cognitive functioning. |
No Intervention: 4
Recreational activities are not tailored to either style of interest or function
|
- Agitation [ Time Frame: During activity intervention, random times outside of activity intervention (during the intervention period), and one week post intervention period ]
- Passivity [ Time Frame: During activity intervention, random times outside of activity intervention (during the intervention period), and one week post intervention period ]
- Mood [ Time Frame: During activity intervention, random times outside of activity intervention (during the intervention period), and one week post intervention period ]
- Affect [ Time Frame: During activity intervention, random times outside of activity intervention (during the intervention period), and one week post intervention period ]
- Engagement [ Time Frame: During activity intervention, random times outside of activity intervention (during the intervention period), and one week post intervention period ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 65 Years and older (Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- English speaking; diagnosis of dementia; a willing informant who knows the subject well and who can provide past personality and other data; a stable dose of any psychoactive drug from pre-baseline through final observation; and presence of agitation or passivity.
Exclusion Criteria:
- delirium or an unstable medical condition; history of Parkinson's disease, Huntington's disease, seizure disorder, stroke, alcoholism, drug abuse, head trauma with loss of consciousness, or psychiatric illness preceding the onset of memory loss; severe vision or hearing impairment; and receiving a new psychoactive medication within the past 30 days.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00388544
United States, Pennsylvania | |
Nursing homes in Central and Northeast Pennsylvania | |
University Park, Pennsylvania, United States, 16802 |
Principal Investigator: | Ann Kolanowski, PhD, RN | Penn State University |
Other Publications:
Responsible Party: | Ann Kolanowski, Professor of Nursing, Penn State University |
ClinicalTrials.gov Identifier: | NCT00388544 |
Other Study ID Numbers: |
19150 R01NR008910 ( U.S. NIH Grant/Contract ) R01NR008910-01A1 ( U.S. NIH Grant/Contract ) |
First Posted: | October 17, 2006 Key Record Dates |
Last Update Posted: | May 9, 2012 |
Last Verified: | May 2012 |
Alzheimer Disease Dementia Brain Diseases Central Nervous System Diseases Nervous System Diseases |
Tauopathies Neurodegenerative Diseases Neurocognitive Disorders Mental Disorders |